— Know what they know.
Not Investment Advice
Also trades as: TTKHEALTH.BO (BSE) · $vol 0M

TTKHLTCARE.NS NSE

TTK Healthcare Limited
1W: -3.1% 1M: -10.2% 3M: +10.9% YTD: +7.0% 1Y: -10.4% 3Y: -12.0% 5Y: +38.5%
₹1,019.10 ($10.59)
+6.10 (+0.60%)
 
NSE · Healthcare · Drug Manufacturers - General · Tech Score Sell · Power 40 · ₹14.3B mcap · 3M float · 0.844% daily turnover

Cash Flow Trends

Operating Cash Flow
-$211M -431.9% ▼
Capital Expenditures
$58M +54.8% ▲
5Y CAGR: +27.3%
Free Cash Flow
-$270M -60.3% ▼
Dividends Paid
$141M +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
$129M +759.3% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2022FY2023FY2024FY2025FY2026
— Operating Activities —
Net Income$578M$8.4B$628M$817M$826M
Depreciation & Amort.$132M$129M$131M$83M$88M
Stock-Based Comp.$0$0$0$0$0
Change in Working Capital-$39M-$452M-$153M-$31M-$326M
Other Non-Cash Items-$221M-$8.3B-$655M-$908M-$798M
Operating Cash Flow$450M-$261M-$49M-$40M-$211M
— Investing Activities —
Capital Expenditures-$65M-$117M-$104M-$128M-$58M
Acquisitions (Net)$26M$7.8B$1M$233M$0
Investment Purchases-$405M-$5.8B-$187M-$557M-$124M
Investment Sales$379M$5.8B$0$0$0
Other Investing-$241M-$7.3B$574M$653M$698M
Investing Cash Flow-$305M$330M$285M$201M$516M
— Financing Activities —
Net Debt Issuance-$5M$51M-$41M$5M-$312K
Stock Repurchased$0$0$0$0$0
Dividends Paid-$85M-$141M-$141M-$141M-$141M
Other Financing$38M-$34M-$37M-$44M-$34M
Financing Cash Flow-$52M-$124M-$219M-$181M-$176M
Net Change in Cash$53M-$55M$16M-$20M$129M
Cash End of Period$149M$93M$110M$90M$219M
Free Cash Flow$385M-$378M-$153M-$168M-$270M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms